Abstract
In almost half of allogeneic hematopoietic progenitor cell (HPC) transplants, a related donor (RD) is used, yet a lack of standardized guidelines means that their care is heterogeneous. Changes to regulatory standards aim to improve uniformity, but adherence to these regulations can prove logistically difficult for the transplant centers (TCs) managing RDs. Discussion has ensued around possible alternative models of related donor care and a session at the European Society for Blood and Marrow Transplantation (EBMT) annual meeting in 2013 debated the question of whether a role exists for unrelated donor registries in the management of 'related' donors. In this overview, we discuss the issues raised at this debate and the pros and cons of donor registry involvement in various aspects of RD management. By examining existing models of related donor care that have been adopted by members of the World Marrow Donor Association (WMDA), we look for ways to enhance and homogenize RD care, while also enabling transplant centers to meet standards required for mandatory accreditation.
References
Dec 1, 1993·Journal of Health and Social Behavior·R G SimmonsV A Butterworth
Mar 7, 1998·Bone Marrow Transplantation·G E SwitzerR G Simmons
Aug 11, 2001·Transplantation Proceedings·R TaghaviH Toufani
Apr 15, 2003·Journal of the American College of Surgeons·Roger S Foster
Sep 28, 2004·Transplantation·UNKNOWN Ethics Committee of the Transplantation Society
Nov 24, 2005·Hematology·Mary M Horowitz, Dennis L Confer
Jan 18, 2006·Pediatric Blood & Cancer·Michael A PulsipherRobert M Nelson
Mar 26, 2008·Bone Marrow Transplantation·N SacchiUNKNOWN Quality Assurance and Clinical Working Groups of the World Marrow Donor Association
Dec 9, 2008·Haematologica·Joerg HalterAlois Gratwohl
Jun 9, 2009·Bone Marrow Transplantation·S ClareUNKNOWN Research Sub-committee of the EBMT Nurses Group
Dec 22, 2009·Bone Marrow Transplantation·S M van WalravenUNKNOWN WMDA Ethics and Clinical working groups
Mar 17, 2010·Blood·Paul V O'DonnellUNKNOWN Donor Health and Safety Working Committee from Center for International Blood and Marrow Transplant Research (CIBMTR)
Jul 2, 2011·Haematologica·Bronwen E ShawMichael A Pulsipher
Dec 14, 2011·Blood·Jan StyczynskiUNKNOWN European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party
Jan 25, 2012·Psycho-oncology·S M van WalravenR M Egeler
Mar 24, 2012·Blood·Michael A Pulsipher
May 5, 2012·Transfusion·Johanna C Wiersum-OsseltonAnneke Brand
Jun 19, 2012·Bone Marrow Transplantation·S M van WalravenL M Ball
Jul 10, 2012·Bone Marrow Transplantation·J P HalterD Confer
Oct 1, 2013·Bone Marrow Transplantation·Y KoderaUNKNOWN European Blood and Marrow Transplant Group
Apr 30, 2014·Pediatrics·Rebecca D PentzPamela Hinds
Citations
Feb 24, 2016·Transfusion·Chloe AnthiasBronwen E Shaw
Mar 24, 2016·Seminars in Hematology·Andrea Bacigalupo, Simona Sica
May 3, 2016·Transplantation·Jeff SzerJerry Stein
Sep 7, 2016·Bone Marrow Transplantation·C AnthiasB E Shaw
Oct 3, 2018·European Journal of Cancer Care·Nienke ZomerdijkGeoffrey R Hill
Oct 4, 2019·Bone Marrow Transplantation·A PolomeniJ Stringer
Nov 25, 2016·Blood·Wendy Kohlmann, Joshua D Schiffman
Dec 4, 2016·Hematology·Wendy Kohlmann, Joshua D Schiffman
Jul 7, 2017·Stem Cells International·Irene RiezzoEmanuela Turillazzi
Oct 27, 2020·Vox Sanguinis·Christina MikkelsenHenrik Ullum
Apr 11, 2021·Transplantation and Cellular Therapy·Matthew D SeftelMichael A Pulsipher
Jun 9, 2020·Leukemia Research·Almudena Aguilera-DiazMaría José Calasanz